Trial Profile
Clinical Trials Insight: 700027655
Status:
Planning
Phase of Trial:
Phase IV
Latest Information Update: 15 Oct 2007
Price :
$35
*
At a glance
- Drugs Zotarolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Adverse reactions
- Sponsors Medtronic
- 15 Oct 2007 New trial record.